On August 22, 2012, the U.S. Securities and Exchange Commission (SEC) adopted a final rule to implement reporting and disclosure related to “conflict minerals”, as directed by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The rule requires manufacturers who are SEC filers to disclose whether the product they manufacture or contract to manufacture contain “conflict minerals” that are “necessary to the functionality or production” of those products.
Conflict minerals refer to columbite-tantalite (coltan), cassiterite, gold, wolframite, and their derivatives, which are limited to tin, tantalum, and tungsten (commonly referred to as 3T&G), regardless of where such minerals are sourced, processed or sold. The intent of these requirements is to further the goal of ending violent conflict in the Democratic republic of the Congo (DRC) and in adjoining countries, which has been financed, in part, by the exploitation and trade of conflict minerals.
Uroplasty’s Conflict Minerals Policy Statement
Uroplasty is committed to ensure that conflict minerals contained in our products are sourced with due respect for human rights, the need to avoid contributing to conflict, and the desire to support development through our supply chain practices.
At the same time, Uroplasty does not ban the use of conflict minerals that originate in conflict-affected and high-risk areas when they are sourced in accordance with existing international standards. Avoiding the sourcing of all conflict minerals from these areas would cause a de facto embargo with serious adverse impact on the living conditions of local populations.
Uroplasty has established a conflict minerals compliance program that is designed to follow the framework established by The Organization for Economic Co-operation and Development (the “OECD”) for providing sourcing expectations to our suppliers, and meeting the sourcing expectations of our customers, regulators and stakeholders.
Concerns or reports of possible violations of this policy can be reported confidentially via email at: firstname.lastname@example.org.
Uroplasty has filed a specialized report on From SD, including a Conflict Minerals Report, for the year ended December 31, 2013, with the SEC.